Cancer News Video Abstract - Dr. Daneng Li
Вставка
- Опубліковано 29 вер 2024
- NRG/RTOG 1112, a randomized phase III study of sorafenib versus stereotactic body radiation therapy followed by sorafenib in patients with hepatocellular carcinoma, shared by Dr. Daneng Li of City of Hope.